Radiation Oncology 2024 Subscription-Based Review


Sample Video:
If you have enrolled in this review and are still viewing the sample, click here to login

Still, see the sample video. Please perform a hard refresh of your browser. More info here.

Available as in 3, 6, and  12-month options. Starting as low as $695.00.

Release Date: May 21, 2024


By providing your month and day of birth, state of licensure, and license ID, you are permitting to have your CME/MOC completion data reported to your licensing/certifying board.

This information is only required if you choose to have Osler report your CME activities to the boards that participate in the ACCME reporting program.

This information is only required if you choose to have Osler report your CME activities to the boards that participate in the ACCME reporting program.


The Osler Institute recorded our Live Virtual Webinar April 2024 comprehensive Radiation Oncology Review Course and bring it to you! These Video files are stored “in the cloud,” so you can stream them anywhere, anytime, as long as you have an internet connection, watch or listen to them on your phone, computer, or tablet – your learning experience is almost like being at the live activity but without travel costs and time away from your practice. In addition, each online review is a downloadable copy of the syllabus corresponding to the Video lectures for your use while viewing or as a free-standing study or clinical practice guide.

This Subscription-Based Review provides senior trainees and clinicians in practice a comprehensive update of clinical knowledge. It helps prepare them for their Radiation Oncology exams (the initial certification and MOC). Emphasis is on evidence-based medicine, board-relevant standards of care, and new concepts, treatments, and imaging approaches. The written exams emphasize anatomy, epidemiology, etiological agents, natural history, pathology, tumor markers, initial clinical evaluation, staging, routes of spread, selection of treatment modality and techniques, surgical and adjuvant chemotherapy treatments, follow-up treatment and assessment, patterns of failure, and normal tissue effects including complications; all of these areas are addressed. The review also covers the basic principles of radiobiology and physics relevant to clinical practice.


Release Date: May 21, 2024
Expiration Date: May 20, 2027
Estimated Time to Complete: 38 hours

Accreditation Statement

The Osler Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

The Osler Institute designates this Enduring Material activity for a maximum of 35 AMA PRA Category 1 Credit(s)™. Each physician should claim only the credit commensurate with the extent of their participation in the activity.

Required Physician Participation:

Review the audio/video lectures at your own pace. To claim CME credit, Learners must complete a self-assessment post-test (a score of 75% or greater is required) and activity evaluation to test knowledge gained and its application to your practice. You may take the test and utilize the accompanying syllabus by accessing the links provided. More than one test attempt is allowed, and feedback is provided.

Financial Disclosure

Faculty, Planner, and Reviewer Disclosure Declaration

In compliance with the Standards, Guidelines, and Ethical opinions of the ACCME, AAMC, and AMA, The Osler Institute requires that anyone with input into the planning or presentation of Continuing Medical Education activities provided or jointly provided by The Osler Institute must disclose to the program audience any relevant financial relationships with companies or organizations about whose products or services they are discussing in their presentations.

The following faculty/planners/reviewers disclosed a relevant financial relationship(s).


The following faculty/planners/reviewers listed no relevant financial relationship(s) to disclose.

DMusaddiq Awan MD
Ralph Vatner, MD, PhD
Vatsal Patel, MD, MBA, DABR
Paras Khandhar, MD, FAAFP
S. Peter Wu, MD
Steven Lin, MD, PhD
Jillian Gunther MD, PhD
Allison Quick MD
Shalin J Shah MD
Todd Swanson, MD, PhD†*
John Burns†
Joseph Selliken, MD†
Michael Stewart†
Erin Baynard†

Copies of the Faculty Disclosure Forms are available upon request.
† Program Planning Committee
* Reviewer, if Applicable

Faculty and Topics

Musaddiq Awan MDMusaddiq Awan MD

Head and Neck Cancer I – III



Ralph Vatner, MD, PhDRalph Vatner, MD, PhD

Pediatric Brain Tumors
Brain Stem Glioma
Intracranial Germ Cell Tumors
Pediatric Gliomas
Pediatric CNS Questions
Wilms Tumor
Ewing’s Sarcoma
Pediatric Solid Questions

Paras Khandhar, MD, FAAP

Statistics, Evidence-Based Medicine (EBM)
Patient Safety & Quality Improvement


S. Peter Wu, MD
S. Peter Wu, MD

Early Stage Breast Cancer
Locally Advanced Breast Cancer
Carcinoma-in-situ and Misc (DCIS)


Todd Swanson, MD, PhD†

CNS Overview
Primary CNS Malignancies
CNS Metastasis of the Brain
CNS Metastasis Spine
Benign Disorders of CNS
Palliative Care
†Course Planning Committee

Steven Lin, MD, Ph.D.

Early-stage NSCLC
Locally Advanced NSCLC
Small Cell Lung Cancer
Rare Mediastinal Tumors

Jillian R. Gunther, MD PhD

Hodgkin Lymphoma
Non-Hodgkin Lymphoma
Multiple Myeloma and Solitary Plasmacytoma


Allison Quick MDAllison Quick, MD

Endometrial Cancer
Cervical Cancer
Vulvar Cancer


Image Coming Soon 3Vatsal Patel, MD, MBA, DABR

Anal Cancer
Colon Cancer
Bile Duct Cancer
Esophageal Cancer
Rectal Cancer
Gastric Cancer
Colon Cancer
Liver Cancer
Pancreatic Ampullary Cancer

Shalin J Shah MDShalin Shah, MD

Bladder, Ureter, Penile Cancer
Germ Cell, Kidney, Renal Pelvis Cancer
Early and Intermediate-Risk Prostate Cancer
High Risk and Metastatic Prostate Cancer
Adjuvant/Salvage Prostate Cancer


After this review, each participant should be able to perform the following tasks for all cancers of the eleven ABR-defined component areas:

  • Describe the anatomy, epidemiology/etiologic agents, and natural history
    Explain the pathology and use of tumor markers
  • Describe the initial clinical evaluation, staging, and routes of disease spread (local and distant)
  • Summarize potential treatment modalities, including optimum beam and radiation sources, volume and dose calculations, and fractionation.
  • Discuss follow-up treatment and evaluation, patterns of failure, and normal tissue effects.
  • Discuss multimodality therapies, including sequence, interactions, and specific agents.
  • Describe brachytherapy applications and issues for all disease sites
    Outline the use of palliative care for brain, hepatic, and skeletal lesions, plus various obstructive scenarios
  • Implement a basic program of ethics, patient safety, and quality assurance in clinical practice


The Osler Institute takes pride in providing the highest quality education to our learners. We offer courses that are guaranteed to help them confidently pass their examinations. In the unlikely event of a learner not passing their examination, we offer the opportunity to re-enroll in the same course tuition-free until they succeed.  For complete information on this guarantee, we invite you to review our comprehensive Terms and Conditions.

How-To and Player Help

jwplayer help

The player controls left to right.

    1. Play
    2. Rewind 10 sec
    3. Next up
    4. Volume
    5. Time Played/ Total Time
    6. More Videos
    7. Settings
      Playback Rates
    8. Full Screen

7. Settings, Quality, and Playback Rates



All Subscription-Based Reviews are accessed from the page that they were purchased from.

Group Discounts Available

If you have two or three residents interested in participating in live virtual or subscription-based reviews, you are eligible for a 35% discount when registering!

If you have four or more residents interested in participating in live virtual or subscription-based reviews, you are eligible for a 50% discount when registering!

Contact us for details; call 1-800-356-7537 or

Group Discount Program has conditions that cannot be combined with other discounts or offers.